ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 289074 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 289074; 2) Community: the network communities that were significantly associated with the response to NSC 289074; 3) Molecule: the relationships between components within communities and NSC 289074; 4) MDR: the compounds that were significantly associated with the NSC 289074.

NSC Compound Enrichment Correlation
NSC 735406 Null 0.0406225271888776 0.37469565
NSC 750285 DP1 0.0406225271888776 -0.05032245
NSC 752330 6-(2-(propan-2-ylidene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0406225271888776 0.12713814
NSC 753203 N-(2-(4-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-4-methoxybenzamide 0.0406225271888776 0.06249236
NSC 756258 GW569530A 0.0406225271888776 -0.18905832
NSC 19441 FDA 0283 0.0407060322613561 0.07840366
NSC 298223 Antibiotic CC 1065 (9CI) 0.0407060322613564 -0.1183931
NSC 302288 BOHLMANN K2630 0.0407060322613564 0.43682496
NSC 348402 Null 0.0407060322613564 0.54592737
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0407060322613564 -0.068005203
Total:70  Current:64    [First] [Prev] [Next] [Last]